APO Research
Talk to an analyst

APO RESEARCH · REPORT

Assisted Reproductive Technologies Medications

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Assisted Reproductive Technologies Medications Market Outlook and Growth Opportunities 2026

21 December 2025190 pages

Choose your research edition.

Industry ResearchAssisted Reproductive Technologies Medications Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Assisted Reproductive Technologies Medications Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Assisted Reproductive Technologies Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Assisted Reproductive Technologies Medications Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Assisted Reproductive Technologies Medications Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Assisted Reproductive Technologies Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Assisted Reproductive Technologies Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Assisted Reproductive Technologies Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Assisted Reproductive Technologies Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Assisted Reproductive Technologies Medications market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Assisted Reproductive Technologies Medications market include Zhejiang Xianju, Merck Serono, Livzon Pharmaceutical, Changchun GeneScience, Hybio Pharmaceutical, Solvay, Organon, Ipsen and Ferring, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Assisted Reproductive Technologies Medications market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Assisted Reproductive Technologies Medications and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Assisted Reproductive Technologies Medications revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Assisted Reproductive Technologies Medications market.

Assisted Reproductive Technologies Medications Segment by Company

Zhejiang Xianju

Merck Serono

Livzon Pharmaceutical

Changchun GeneScience

Hybio Pharmaceutical

Solvay

Organon

Ipsen

Ferring

Besins

Assisted Reproductive Technologies Medications Segment by Type

Ovulation Stimulation Drugs

Luteal Support Medications

Down-Regulation Drugs

Ovulation Inducing Drugs

Assisted Reproductive Technologies Medications Segment by Application

Specialty & Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Assisted Reproductive Technologies Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Assisted Reproductive Technologies Medications status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Assisted Reproductive Technologies Medications key companies, revenue, market share, and recent developments.

3. To split the Assisted Reproductive Technologies Medications breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Assisted Reproductive Technologies Medications market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Assisted Reproductive Technologies Medications significant trends, drivers, influence factors in global and regions.

6. To analyze Assisted Reproductive Technologies Medications competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Assisted Reproductive Technologies Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Assisted Reproductive Technologies Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Assisted Reproductive Technologies Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Assisted Reproductive Technologies Medications industry.

Chapter 3: Detailed analysis of Assisted Reproductive Technologies Medications company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Assisted Reproductive Technologies Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Assisted Reproductive Technologies Medications in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Assisted Reproductive Technologies Medications Industry Trends Table 2. Assisted Reproductive Technologies Medications Industry Drivers Table 3. Assisted Reproductive Technologies Medications Industry Opportunities and Challenges Table 4. Assisted Reproductive Technologies Medications Industry Restraints Table 5. Global Assisted Reproductive Technologies Medications Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Assisted Reproductive Technologies Medications Revenue Share by Company (2021-2026) Table 7. Global Assisted Reproductive Technologies Medications Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Assisted Reproductive Technologies Medications Key Company Manufacturing Base & Headquarters Table 9. Global Assisted Reproductive Technologies Medications Company, Product Type & Application Table 10. Global Assisted Reproductive Technologies Medications Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Assisted Reproductive Technologies Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Ovulation Stimulation Drugs Table 15. Significant Companies of Luteal Support Medications Table 16. Significant Companies of Down-Regulation Drugs Table 17. Significant Companies of Ovulation Inducing Drugs Table 18. Global Assisted Reproductive Technologies Medications Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Assisted Reproductive Technologies Medications Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Assisted Reproductive Technologies Medications Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Assisted Reproductive Technologies Medications Sales Value Share by Type (2021-2026) Table 22. Global Assisted Reproductive Technologies Medications Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Specialty & Retail Pharmacy Table 24. Significant Companies of Hospital Pharmacy Table 25. Significant Companies of Online Pharmacy Table 26. Global Assisted Reproductive Technologies Medications Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Assisted Reproductive Technologies Medications Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Assisted Reproductive Technologies Medications Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Assisted Reproductive Technologies Medications Sales Value Share by Application (2021-2026) Table 30. Global Assisted Reproductive Technologies Medications Sales Value Share by Application (2027-2032) Table 31. Global Assisted Reproductive Technologies Medications Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Assisted Reproductive Technologies Medications Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Assisted Reproductive Technologies Medications Sales Value Share by Region (2021-2026) Table 34. Global Assisted Reproductive Technologies Medications Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Assisted Reproductive Technologies Medications Sales Value Share by Region (2027-2032) Table 36. Global Assisted Reproductive Technologies Medications Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Assisted Reproductive Technologies Medications Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Assisted Reproductive Technologies Medications Sales Value Market Share by Country (2021-2026) Table 39. Global Assisted Reproductive Technologies Medications Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Assisted Reproductive Technologies Medications Sales Value Market Share by Country (2027-2032) Table 41. Zhejiang Xianju Company Information Table 42. Zhejiang Xianju Business Overview Table 43. Zhejiang Xianju Assisted Reproductive Technologies Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Zhejiang Xianju Assisted Reproductive Technologies Medications Product Portfolio Table 45. Zhejiang Xianju Recent Development Table 46. Merck Serono Company Information Table 47. Merck Serono Business Overview Table 48. Merck Serono Assisted Reproductive Technologies Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Merck Serono Assisted Reproductive Technologies Medications Product Portfolio Table 50. Merck Serono Recent Development Table 51. Livzon Pharmaceutical Company Information Table 52. Livzon Pharmaceutical Business Overview Table 53. Livzon Pharmaceutical Assisted Reproductive Technologies Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Livzon Pharmaceutical Assisted Reproductive Technologies Medications Product Portfolio Table 55. Livzon Pharmaceutical Recent Development Table 56. Changchun GeneScience Company Information Table 57. Changchun GeneScience Business Overview Table 58. Changchun GeneScience Assisted Reproductive Technologies Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Changchun GeneScience Assisted Reproductive Technologies Medications Product Portfolio Table 60. Changchun GeneScience Recent Development Table 61. Hybio Pharmaceutical Company Information Table 62. Hybio Pharmaceutical Business Overview Table 63. Hybio Pharmaceutical Assisted Reproductive Technologies Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Hybio Pharmaceutical Assisted Reproductive Technologies Medications Product Portfolio Table 65. Hybio Pharmaceutical Recent Development Table 66. Solvay Company Information Table 67. Solvay Business Overview Table 68. Solvay Assisted Reproductive Technologies Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Solvay Assisted Reproductive Technologies Medications Product Portfolio Table 70. Solvay Recent Development Table 71. Organon Company Information Table 72. Organon Business Overview Table 73. Organon Assisted Reproductive Technologies Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Organon Assisted Reproductive Technologies Medications Product Portfolio Table 75. Organon Recent Development Table 76. Ipsen Company Information Table 77. Ipsen Business Overview Table 78. Ipsen Assisted Reproductive Technologies Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Ipsen Assisted Reproductive Technologies Medications Product Portfolio Table 80. Ipsen Recent Development Table 81. Ferring Company Information Table 82. Ferring Business Overview Table 83. Ferring Assisted Reproductive Technologies Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Ferring Assisted Reproductive Technologies Medications Product Portfolio Table 85. Ferring Recent Development Table 86. Besins Company Information Table 87. Besins Business Overview Table 88. Besins Assisted Reproductive Technologies Medications Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Besins Assisted Reproductive Technologies Medications Product Portfolio Table 90. Besins Recent Development Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Assisted Reproductive Technologies Medications Product Image Figure 2. Global Assisted Reproductive Technologies Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Assisted Reproductive Technologies Medications Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Ovulation Stimulation Drugs Image Figure 8. Luteal Support Medications Image Figure 9. Down-Regulation Drugs Image Figure 10. Ovulation Inducing Drugs Image Figure 11. Global Assisted Reproductive Technologies Medications Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Assisted Reproductive Technologies Medications Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Assisted Reproductive Technologies Medications Sales Value Share by Type (2021-2032) Figure 14. Specialty & Retail Pharmacy Image Figure 15. Hospital Pharmacy Image Figure 16. Online Pharmacy Image Figure 17. Global Assisted Reproductive Technologies Medications Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Assisted Reproductive Technologies Medications Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Assisted Reproductive Technologies Medications Sales Value Share by Application (2021-2032) Figure 20. Global Assisted Reproductive Technologies Medications Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Assisted Reproductive Technologies Medications Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Assisted Reproductive Technologies Medications Sales Value (2021-2032) & (US$ Million) Figure 23. North America Assisted Reproductive Technologies Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Assisted Reproductive Technologies Medications Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Assisted Reproductive Technologies Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Assisted Reproductive Technologies Medications Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Assisted Reproductive Technologies Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Assisted Reproductive Technologies Medications Sales Value (2021-2032) & (US$ Million) Figure 29. South America Assisted Reproductive Technologies Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Assisted Reproductive Technologies Medications Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Assisted Reproductive Technologies Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Ovulation Stimulation Drugs
  • Luteal Support Medications
  • Down-Regulation Drugs
  • Ovulation Inducing Drugs
Applications
  • Specialty & Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
Companies covered
  • Zhejiang Xianju
  • Merck Serono
  • Livzon Pharmaceutical
  • Changchun GeneScience
  • Hybio Pharmaceutical
  • Solvay
  • Organon
  • Ipsen
  • Ferring
  • Besins

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Assisted Reproductive Technologies Medications Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Assisted Reproductive Technologies Medications Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Assisted Reproductive Technologies Medications Market Dynamics
  1. 2.1 Assisted Reproductive Technologies Medications Industry Trends
  2. 2.2 Assisted Reproductive Technologies Medications Industry Drivers
  3. 2.3 Assisted Reproductive Technologies Medications Industry Opportunities and Challenges
  4. 2.4 Assisted Reproductive Technologies Medications Industry Restraints
3 Assisted Reproductive Technologies Medications Market by Company
  1. 3.1 Global Assisted Reproductive Technologies Medications Company Revenue Ranking in 2025
  2. 3.2 Global Assisted Reproductive Technologies Medications Revenue by Company (2021-2026)
  3. 3.3 Global Assisted Reproductive Technologies Medications Company Ranking (2024-2026)
  4. 3.4 Global Assisted Reproductive Technologies Medications Company Manufacturing Base and Headquarters
  5. 3.5 Global Assisted Reproductive Technologies Medications Company Product Type and Application
  6. 3.6 Global Assisted Reproductive Technologies Medications Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Assisted Reproductive Technologies Medications Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Assisted Reproductive Technologies Medications Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Assisted Reproductive Technologies Medications Market by Type
  1. 4.1 Assisted Reproductive Technologies Medications Type Introduction
  2. 4.1.1 Ovulation Stimulation Drugs
  3. 4.1.2 Luteal Support Medications
  4. 4.1.3 Down-Regulation Drugs
  5. 4.1.4 Ovulation Inducing Drugs
  6. 4.2 Global Assisted Reproductive Technologies Medications Sales Value by Type
  7. 4.2.1 Global Assisted Reproductive Technologies Medications Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Assisted Reproductive Technologies Medications Sales Value by Type (2021-2032)
  9. 4.2.3 Global Assisted Reproductive Technologies Medications Sales Value Share by Type (2021-2032)
5 Assisted Reproductive Technologies Medications Market by Application
  1. 5.1 Assisted Reproductive Technologies Medications Application Introduction
  2. 5.1.1 Specialty & Retail Pharmacy
  3. 5.1.2 Hospital Pharmacy
  4. 5.1.3 Online Pharmacy
  5. 5.2 Global Assisted Reproductive Technologies Medications Sales Value by Application
  6. 5.2.1 Global Assisted Reproductive Technologies Medications Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Assisted Reproductive Technologies Medications Sales Value by Application (2021-2032)
  8. 5.2.3 Global Assisted Reproductive Technologies Medications Sales Value Share by Application (2021-2032)
6 Assisted Reproductive Technologies Medications Regional Value Analysis
  1. 6.1 Global Assisted Reproductive Technologies Medications Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Assisted Reproductive Technologies Medications Sales Value by Region (2021-2032)
  3. 6.2.1 Global Assisted Reproductive Technologies Medications Sales Value by Region: 2021-2026
  4. 6.2.2 Global Assisted Reproductive Technologies Medications Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Assisted Reproductive Technologies Medications Sales Value (2021-2032)
  7. 6.3.2 North America Assisted Reproductive Technologies Medications Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Assisted Reproductive Technologies Medications Sales Value (2021-2032)
  10. 6.4.2 Europe Assisted Reproductive Technologies Medications Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Assisted Reproductive Technologies Medications Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Assisted Reproductive Technologies Medications Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Assisted Reproductive Technologies Medications Sales Value (2021-2032)
  16. 6.6.2 South America Assisted Reproductive Technologies Medications Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Assisted Reproductive Technologies Medications Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Assisted Reproductive Technologies Medications Sales Value Share by Country, 2025 VS 2032
7 Assisted Reproductive Technologies Medications Country-level Value Analysis
  1. 7.1 Global Assisted Reproductive Technologies Medications Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Assisted Reproductive Technologies Medications Sales Value by Country (2021-2032)
  3. 7.2.1 Global Assisted Reproductive Technologies Medications Sales Value by Country (2021-2026)
  4. 7.2.2 Global Assisted Reproductive Technologies Medications Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Assisted Reproductive Technologies Medications Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Assisted Reproductive Technologies Medications Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Assisted Reproductive Technologies Medications Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Xianju
  2. 8.1.1 Zhejiang Xianju Company Information
  3. 8.1.2 Zhejiang Xianju Business Overview
  4. 8.1.3 Zhejiang Xianju Assisted Reproductive Technologies Medications Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Xianju Assisted Reproductive Technologies Medications Product Portfolio
  6. 8.1.5 Zhejiang Xianju Recent Developments
  7. 8.2 Merck Serono
  8. 8.2.1 Merck Serono Company Information
  9. 8.2.2 Merck Serono Business Overview
  10. 8.2.3 Merck Serono Assisted Reproductive Technologies Medications Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Serono Assisted Reproductive Technologies Medications Product Portfolio
  12. 8.2.5 Merck Serono Recent Developments
  13. 8.3 Livzon Pharmaceutical
  14. 8.3.1 Livzon Pharmaceutical Company Information
  15. 8.3.2 Livzon Pharmaceutical Business Overview
  16. 8.3.3 Livzon Pharmaceutical Assisted Reproductive Technologies Medications Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Livzon Pharmaceutical Assisted Reproductive Technologies Medications Product Portfolio
  18. 8.3.5 Livzon Pharmaceutical Recent Developments
  19. 8.4 Changchun GeneScience
  20. 8.4.1 Changchun GeneScience Company Information
  21. 8.4.2 Changchun GeneScience Business Overview
  22. 8.4.3 Changchun GeneScience Assisted Reproductive Technologies Medications Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Changchun GeneScience Assisted Reproductive Technologies Medications Product Portfolio
  24. 8.4.5 Changchun GeneScience Recent Developments
  25. 8.5 Hybio Pharmaceutical
  26. 8.5.1 Hybio Pharmaceutical Company Information
  27. 8.5.2 Hybio Pharmaceutical Business Overview
  28. 8.5.3 Hybio Pharmaceutical Assisted Reproductive Technologies Medications Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hybio Pharmaceutical Assisted Reproductive Technologies Medications Product Portfolio
  30. 8.5.5 Hybio Pharmaceutical Recent Developments
  31. 8.6 Solvay
  32. 8.6.1 Solvay Company Information
  33. 8.6.2 Solvay Business Overview
  34. 8.6.3 Solvay Assisted Reproductive Technologies Medications Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Solvay Assisted Reproductive Technologies Medications Product Portfolio
  36. 8.6.5 Solvay Recent Developments
  37. 8.7 Organon
  38. 8.7.1 Organon Company Information
  39. 8.7.2 Organon Business Overview
  40. 8.7.3 Organon Assisted Reproductive Technologies Medications Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Organon Assisted Reproductive Technologies Medications Product Portfolio
  42. 8.7.5 Organon Recent Developments
  43. 8.8 Ipsen
  44. 8.8.1 Ipsen Company Information
  45. 8.8.2 Ipsen Business Overview
  46. 8.8.3 Ipsen Assisted Reproductive Technologies Medications Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ipsen Assisted Reproductive Technologies Medications Product Portfolio
  48. 8.8.5 Ipsen Recent Developments
  49. 8.9 Ferring
  50. 8.9.1 Ferring Company Information
  51. 8.9.2 Ferring Business Overview
  52. 8.9.3 Ferring Assisted Reproductive Technologies Medications Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ferring Assisted Reproductive Technologies Medications Product Portfolio
  54. 8.9.5 Ferring Recent Developments
  55. 8.10 Besins
  56. 8.10.1 Besins Company Information
  57. 8.10.2 Besins Business Overview
  58. 8.10.3 Besins Assisted Reproductive Technologies Medications Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Besins Assisted Reproductive Technologies Medications Product Portfolio
  60. 8.10.5 Besins Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst